Ketamine-a Narrative Review of Its Uses in Medicine

1. Best W, Bodenschatz C, Beran D. Earth Health Organization Critical Review of Ketamine. 36th WHO Good Committee on Drug Dependence written report, 6.ii. Geneva: World Wellness Arrangement; 2014. Report No.: WHO technical report series no 991.

ii. Dolansky Yard, Shah A, Mosdossy G, Rieder Thousand. What is the bear witness for the rubber and efficacy of using ketamine in children? Paediatr Child Wellness 2008; xiii: 307-eight.
pmid pmc

iii. Pai A, Heining G. Ketamine. Cont Educ Anesth Crit Care Pain 2007; seven: 59-63.
crossref

4. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101: 524-34.
crossref pmid

v. Filanovsky Y, Miller P, Kao J. Myth: Ketamine should not be used equally an induction agent for intubation in patients with head injury. CJEM 2010; 12: 154-7.
crossref pmid

6. Hughes S. Is ketamine a viable induction agent for the trauma patient with potential brain injury. BestBETs [Net]. 2011 Nov xxx [cited 2020 Dec 17]. Available from www.bestbets.org/bets/bet.php?id=2180

7. Zeiler FA, Teitelbaum J, Due west M, Gillman LM. The ketamine effect on ICP in traumatic encephalon injury. Neurocrit intendance 2014; 21: 163-73.
crossref pmid

8. Kurdi MS, Theerth KA, Deva RS. Ketamine: Electric current applications in anesthesia, pain, and critical care. Anesth Essays Res 2014; 8: 283-90.
crossref pmid pmc

9. Hudetz JA, Pagel PS. Neuroprotection past ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth 2010; 24: 131-42.
crossref pmid

ten. Vallerand AH, Sanoski CA, Deglin JH. Davis'due south drug guide for nurses. 15th ed. Philadelphia, F.A. Davis Company. 2016.

eleven. Murray MJ. Faust's anesthesiology review. 4th ed. Philadelphia, Elsevier Saunders. 2015, p 166.

12. Corssen G, Hoy JE. A new parenteral anesthetic-CI-581: its issue on intraocular pressure. J Pediatr Ophthalmol Strabismus 1967; four: 20-3.
pdf

thirteen. Drayna PC, Estrada C, Wang W, Saville BR, Arnold DH. Ketamine sedation is not associated with clinically meaningful pinnacle of intraocular pressure. Am J Emerg Med 2012; 30: 1215-8.
pmid

14. Ruiz-Villa JO, Jaramillo-Rivera DA, Pineda-Gutierrez LM. Ketamine affect on intraocular pressure level of children: a systematic review and qualitative synthesis of testify. Colomb J Anesthesiol 2019; 47: 226-35.
pdf

15. Cohen SP, Liao W, Gupta A, Plunkett A. Ketamine in pain direction. Adv Psychosom Med 2011; xxx: 139-61.
crossref pmid

16. Niesters M, Aarts L, Sarton East, Dahan A. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept report. Br J Anaesth 2013; 110: 1010-six.
crossref pmid

17. Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, et al. Consensus guidelines on the utilise of intravenous ketamine infusions for acute hurting management from the American Society of Regional Anesthesia and Hurting Medicine, the American University of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med 2018; 43: 456-66.
crossref pmid pmc

xviii. Bong RF. Ketamine for chronic noncancer hurting: concerns regarding toxicity. Curr Opin Support Palliat Care 2012; 6: 183-7.
crossref pmid

19. Reich DL, Silvay G. Ketamine: an update on the starting time twenty-five years of clinical experience. Can J Anaesth 1989; 36: 186-97.
crossref pmid

20. Kator S, Correll DJ, Ou JY, Levinson R, Noronha GN, Adams CD. Assessment of low-dose i.v. ketamine infusions for adjunctive analgesia. Am J Health Syst Pharm 2016; 73(v Suppl 1): S22-9.
crossref pmid

21. Bong RF, Dahl JB, Moore RA, Kalso EA. WITHDRAWN: Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2015; (7): CD004603.
crossref pmid

22. Feltracco P, Barbieri South, Rizzi Southward, Ori C, Groppa F, De Rosa K, et al. Brief report: perioperative analgesic efficacy and plasma concentrations of S+ -ketamine in continuous epidural infusion during thoracic surgery. Anesth Analg 2013; 116: 1371-5.
crossref pmid

23. Abdel-Ghaffar HS, Salem MA. Rubber and analgesic efficacy of pre-empitive intranasal ketamine versus intranasal fentanyl in patients undergoing endescopic nasal surgery. J Am Sci 2012; eight: 430-6.
pdf

24. Hosseini Jahromi SA, Hosseini Valami SM, Hatamian S. Comparison between issue of lidocaine, morphine and ketamine spray on mail service-tonsillectomy pain in children. Anesth Pain Med 2012; ii: 17-21.
crossref pmid pmc

25. Ithnin FB, Tan DJ, Xu Twoscore, Tan CH, Sultana R, Sng BL. Depression-dose S+ ketamine in target-controlled intravenous anaesthesia with remifentanil and propofol for open gynaecological surgery: a randomised controlled trial. Indian J Anaesth 2019; 63: 126-33.
pmid pmc

26. Shanthanna H, Huilgol 1000, Manivackam VK. Early and effective apply of ketamine for treatment of phantom limb pain. Indian J Anaesth 2010; 54: 157-ix.
crossref pmid pmc

27. Huge Five, Lauchart 1000, Magerl W, Schelling M, Beyer A, Thieme D, et al. Effects of low-dose intranasal (Due south)-ketamine in patients with neuropathic pain. Eur J Hurting 2010; 14: 387-94.
crossref pmid

28. Blonk MI, Koder BG, van den Bemt PM, Huygen FJ. Use of oral ketamine in chronic pain direction: a review. Eur J Pain 2010; 14: 466-72.
crossref pmid

29. Michelet D, Brasher C, Horlin AL, Bellon M, Julien-Marsollier F, Vacher T, et al. Ketamine for chronic non-cancer pain: A meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Pain 2018; 22: 632-46.
crossref pmid

xxx. Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional hurting syndrome. Pain Med 2015; 16: 943-69.
crossref pmid

31. Maher DP, Chen 50, Mao J. Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth Analg 2017; 124: 661-74.
crossref pmid

32. Michelet D, Brasher C, Horlin AL, Bellon K, Julien-Marsollier F, Vacher T, et al. Ketamine for chronic not-cancer pain: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Pain 2018; 22: 632-46.
crossref pmid

33. Benítez-Rosario MA, Salinas-Martín A, González-Guillermo T, Feria One thousand. A strategy for conversion from subcutaneous to oral ketamine in cancer pain patients: effect of a i:ane ratio. J Hurting Symptom Manage 2011; 41: 1098-105.
crossref pmid

34. Abdollahpour A, Saffarieh East, Zoroufchi BH. A review on the contempo application of ketamine in direction of anesthesia, pain, and health care. J Family Med Prim Care 2020; nine: 1317-24.
crossref pmid pmc

35. Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2012; xi: CD003351.
crossref pmid

36. Hardy J, Quinn Due south, Fazekas B, Plummer J, Eckermann S, Agar M, et al. Randomized, double-blind, placebo-controlled report to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer hurting. J Clin Oncol 2012; 30: 3611-7.
crossref pmid

37. Jonkman K, van de Donk T, Dahan A. Ketamine for cancer pain: what is the show? Curr Opin Support Palliat Intendance 2017; 11: 88-92.
crossref pmid

38. Gao M, Rejaei D, Liu H. Ketamine utilize in current clinical exercise. Acta Pharmacol Sin 2016; 37: 865-72.
crossref pmid

39. Reardon S. Rave drug tested against depression. Nature 2015; 517: 130-one.
crossref pmid

xl. Salvadore G, Singh JB. Ketamine every bit a fast acting antidepressant: current knowledge and open questions. CNS Neurosci Ther 2013; 19: 428-36.
crossref pmid pmc

41. Reinstatler L, Youssef NA. Ketamine as a potential handling for suicidal ideation: a systematic review of the literature. Drugs R D 2015; xv: 37-43.
crossref pmid pmc

42. Chen MH, Li CT, Lin WC, Hong CJ, Tu PC, Bai YM, et al. Cognitive role of patients with treatment-resistant low later on a single low dose of ketamine infusion. J Bear upon Disord 2018; 241: 1-7.
crossref pmid

43. Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci 2019; 73: 613-27.
crossref pmid pmc

44. Bartova L, Papageorgiou Thousand, Milenkovic I, Dold One thousand, Weidenauer A, Willeit 1000, et al. Rapid antidepressant effect of S-ketamine in schizophrenia. Eur Neuropsychopharmacol 2018; 28: 980-ii.
crossref pmid

45. Duman RS, Li Northward. A neurotrophic hypothesis of depression: function of synaptogenesis in the deportment of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci 2012; 367: 2475-84.
crossref pmid

46. Beurel E, Song Fifty, Jope RS. Inhibition of glycogen synthase kinase-iii is necessary for the rapid antidepressant issue of ketamine in mice. Mol Psychiatry 2011; sixteen: 1068-70.
crossref pmid

47. Hasselmann HW. Ketamine as antidepressant? Electric current state and future perspectives. Curr Neuropharmacol 2014; 12: 57-70.
crossref pmid pmc

48. Dave NM. Premedication and consecration of anaesthesia in paediatric patients. Indian J Anaesth 2019; 63: 713-20.
crossref pmid pmc

49. Stoelting RK, Hillier SC. Nonbarbiturate Intravenous Anaesthetic Drugs. In: Pharmacology and Physiology in Anaesthetic Practice. 4th ed. Philadelphia, Lippincott Williams and Wilkin. 2006, pp 155-78.

50. Poonai N, Canton K, Ali S, Hendrikx S, Shah A, Miller Thou, et al. Intranasal ketamine for procedural sedation and analgesia in children: a systematic review. PLoS Ane 2017; 12: e0173253.
crossref pmid pmc

51. Gyanesh P, Haldar R, Srivastava D, Agrawal PM, Tiwari AK, Singh PK. Comparing between intranasal dexmedetomidine and intranasal ketamine every bit premedication for procedural sedation in children undergoing MRI: A double-blind, randomized, placebo-controlled trial. J Anesth 2014; 28: 12-8.
crossref pmid

52. Khutia SK, Mandal MC, Das S, Basu SR. Intravenous infusion of ketamine-propofol can be an alternative to intravenous infusion of fentanyl-propofol for deep sedation and analgesia in paediatric patients undergoing emergency curt surgical procedures. Indian J Anaesth 2012; 56: 145-50.
crossref pmid pmc

53. Khajavi One thousand, Emami A, Etezadi F, Safari South, Sharifi A, Shariat Moharari R. Conscious sedation and analgesia in colonoscopy: Ketamine/propofol combination has superior patient satisfaction versus fentanyl/propofol. Anesth Pain Med 2013; 3: 208-thirteen.
crossref pmid pmc

54. Atashkhoyi S, Negargar S, Hatami-Marandi P. Effects of the add-on of low-dose ketamine to propofol-fentanyl amazement during diagnostic gynaecological laparoscopy. Eur J Obstet Gynecol Reprod Biol 2013; 170: 247-50.
crossref pmid

55. Schnabel A, Poepping DM, Kranke P, Zahn PK, Pogatzki-Zahn EM. Efficacy and agin effects of ketamine as an additive for paediatric caudal amazement: a quantitative systematic review of randomized controlled trials. Br J Anaesth 2011; 107: 601-11.
crossref pmid

56. Dahmani Due south, Michelet D, Abback PS, Wood C, Brasher C, Nivoche Y, et al. Ketamine for perioperative pain management in children: a meta-assay of published studies. Paediatr Anaesth 2011; 21: 636-52.
crossref pmid

57. Aliena SP, Lini C, Chirayath JJ. Comparison of postoperative analgesic issue of caudal bupivacaine with and without ketamine in pediatric subumbilical surgeries. J Anaesthesiol Clin Pharmacol 2018; 34: 324-7.
pmid

58. Tobias JD. Dexmedetomidine and ketamine: an constructive culling for procedural sedation? Pediatr Crit Care Med 2012; xiii: 423-7.
crossref pmid

59. Char D, Drover DR, Motonaga KS, Gupta S, Miyake CY, Dubin AM, et al. The effects of ketamine on dexmedetomidine-induced electrophysiologic changes in children. Paediatr Anaesth 2013; 23: 898-905.
crossref pmid

threescore. Ibrahem Amin OA, Kamel AA. Effects of adding ketamine to dexmedetomidine on polish recovery from isoflurane anesthesia in adults undergoing endoscopic sinus surgery. Egypt J Anaesth 2020; 36: 50-five.
crossref

61. Sinha SK, Joshiraj B, Chaudhary Fifty, Hayaran Due north, Kaur M, Jain A. A comparison of dexmedetomidine plus ketamine combination with dexmedetomidine alone for awake fiberoptic nasotracheal intubation: a randomized controlled report. J Anaesthesiol Clin Pharmacol 2014; 30: 514-9.
crossref pmid pmc

62. Kim JG, Lee HB, Jeon SB. Combination of dexmedetomidine and ketamine for magnetic resonance imaging sedation. Front Neurol 2019; 10: 416.
crossref pmid pmc

63. Chun EH, Han MJ, Baik HJ, Park HS, Chung RK, Han JI, et al. Dexmedetomidine-ketamine versus dexmedetomidine-midazolam-fentanyl for monitored anesthesia care during chemoport insertion: a prospective randomized study. BMC Anesthesiol 2016; xvi: 49.
crossref pmid

64. Qiao H, Xie Z, Jia J. Pediatric premedication: a double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine. BMC Anesthesiol 2017; 17: 158.
crossref pmid pmc

65. Groth C, Connor 1000, Kaukeinen 1000, Acquisto Northward, Chui SH, Cucci M, et al. Multicentric retrospective review of ketamine employ in the intensive care unit of measurement (ketamine-ICU written report). Crit Care Med 2020; 48: 459.
crossref

66. Umunna BP, Tekwani G, Barounis D, Kettaneh N, Kulstad Eastward. Ketamine for continuous sedation of mechanically ventilated patients. J Emerg Trauma Shock 2015; 8: 11-five.
crossref pmid pmc

67. Yoon SH. Concerns of the anesthesiologist: anesthetic induction in severe sepsis or septic stupor patients. Korean J Anesthesiol 2012; 63: iii-10.
crossref pmid pmc

68. Wong A, Bridegroom NJ, Armahizer MJ, Kane-Gill SL. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother 2015; 49: fourteen-9.
crossref pmid

69. Pizon AF, Lynch MJ, Benedict NJ, Yanta JH, Frisch A, Menke NB, et al. Adjunct ketamine utilize in the management of severe ethanol withdrawal. Crit Intendance Med 2018; 46: e768-71.
crossref pmid

70. Sabharwal Five, Ramsay E, Martinez R, Shumate R, Khan F, Dave H, et al. Propofol-ketamine combination therapy for effective control of super-refractory condition epilepticus. Epilepsy Behav 2015; 52: 264-vi.
crossref pmid

71. Ferlisi Thou, Hocker South, Grade M, Trinka East, Shorvon S. Preliminary results of the global audit of treatment of refractory status epilepticus. Epilepsy Behav 2015; 49: 318-24.
crossref pmid

72. Rosati A, De Masi South, Guerrini R. Ketamine for refractory status epilepticus: a systematic review. CNS Drugs 2018; 32: 997-1009.
crossref pmid

73. Fujikawa DG. Starting ketamine for neuroprotection earlier than its current use as an coldhearted/antiepileptic drug late in refractory status epilepticus. Epilepsia 2019; 60: 373-80.
crossref pmid

74. Ilvento 50, Rosati A, Marini C, L'Erario M, Mirabile 50, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav 2015; 49: 343-six.
crossref pmid

75. Shrestha GS, Joshi P, Chhetri S, Karn R, Acharya SP. Intravenous ketamine for handling of super-refractory convulsive condition epilepticus with septic shock: a report of 2 cases. Indian J Crit Intendance Med 2015; xix: 283-five.
crossref pmid pmc

76. Mogahd MM, Mahran MS, Elbaradi GF. Safe and efficacy of ketamine-dexmedetomidine versus ketamine-propofol combinations for sedation in patients after coronary avenue bypass graft surgery. Ann Card Anaesth 2017; xx: 182-vii.
crossref pmid pmc

77. Mazzeffi M, Johnson G, Paciullo C. Ketamine in adult cardiac surgery and the cardiac surgery Intensive Intendance Unit: An show-based clinical review. Ann Card Anaesth 2015; 18: 202-nine.
crossref pmid pmc

78. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Byrne AJ, Hudetz AG, et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009; 23: 651-7.
crossref pmid

79. Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. Clinically favourable effects of ketamine equally an anaesthetic for electroconvulsive therapy: a retrospective report. Eur Arch Psychiatry Clin Neurosci 2011; 261: 575-82.
crossref pmid

eighty. Firouzian A, Tabassomi F. Is ketamine-propofol mixture (ketofol) an appropriate alternative induction amanuensis for electroconvulsive therapy? Saudi J Anaesth 2013; 7: 476-7.
crossref pmid pmc

81. Yalcin S, Aydoğan H, Selek S, Kucuk A, Yuce HH, Karababa F, et al. Ketofol in electroconvulsive therapy anesthesia: ii stones for one bird. J Anesth 2012; 26: 562-7.
crossref pmid

82. Shams T, El-Masry R. Ketofol-dexmedetomidine combination in ECT: a dial for low and agitation. Indian J Anaesth 2014; 58: 275-80.
crossref pmid

83. Kellner CH, Iosifescu DV. Ketamine and ECT: better lone than together? Lancet Psychiatry 2017; 4: 348-9.
crossref pmid

84. Schwartz J, Murrough JW, Iosifescu DV. Ketamine for handling-resistant depression: recent developments and clinical applications. Evid Based Ment Health 2016; 19: 35-8.
crossref pmid

85. Aigbedia And so, Tobi KU, Amadasun FE. A comparative study of ketamine gargle and lidocaine jelly application for the prevention of postoperative throat pain following general anaesthesia with endotracheal intubation. Niger J Clin Pract 2017; 20: 677-85.
crossref pmid

86. Rudra A, Ray Southward, Chatterjee Southward, Ahmed A, Ghosh Southward. Gargling with ketamine attenuates the postoperative sore throat. Indian J Anaesth 2009; 53: 40-3.
pmid pmc

87. Chan Fifty, Lee ML, Lo YL. Postoperative sore throat and ketamine irrigate. Br J Anaesth 2010; 105: 97.
crossref pmid

88. Ahuja V, Mitra S, Sarna R. Nebulized ketamine decreases incidence and severity of post-operative sore throat. Indian J Anaesth 2015; 59: 37-42.
crossref pmid pmc

89. Sener Due south, Eken C, Schultz CH, Serinken 1000, Ozsarac 1000. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med 2011; 57: 109-14.
crossref pmid

ninety. Lohit K, Srinivas V, Kulkarni C. Shaheen. A clinical evaluation of the effects of administration of midazolam on ketamine-induced emergence miracle. J Clin Diagn Res 2011; 5: 320-3.
pdf

91. Akhlaghi Northward, Payandemehr P, Yaseri M, Akhlaghi AA, Abdolrazaghnejad A. Premedication with midazolam or haloperidol to forbid recovery agitation in adults undergoing procedural sedation with ketamine: a randomized double-blind clinical trial. Ann Emerg Med 2019; 73: 462-9.
crossref pmid

92. Li CC, Wu ST, Cha TL, Sun GH, Yu DS, Meng E. A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan. Sci Rep 2019; 9: 7240.
crossref pmid pmc

93. Yang SS, Jang MY, Lee KH, Hsu WT, Chen YC, Chen WS, et al. Sexual and bladder dysfunction in male person ketamine abusers: a large-scale questionnaire study. PloS One 2018; 13: e0207927.
crossref pmid pmc

94. Chang T, Lin CC, Lin AT, Fan YH, Chen KK. Ketamine-induced uropathy: a new clinical entity causing lower urinary tract symptoms. Depression Urin Tract Symptoms 2012; 4: nineteen-24.
crossref pmid

hookerveren1993.blogspot.com

Source: https://ekja.org/journal/view.php?number=8718

0 Response to "Ketamine-a Narrative Review of Its Uses in Medicine"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel